(Q42955085)

English

Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse

scientific article published on October 1, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 November 2017

Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse (English)

1 reference

Europe PubMed Central

11 November 2017

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

author name string

Christina Reimer

1

1 reference

Europe PubMed Central

11 November 2017

Peter Bytzer

2

1 reference

Europe PubMed Central

11 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2010

1 reference

Europe PubMed Central

11 November 2017

full work available at URL

http://journals.lww.com/00042737-201010000-00005

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

European Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

11 November 2017

22

1 reference

Europe PubMed Central

11 November 2017

10

1 reference

Europe PubMed Central

11 November 2017

1182-1188

1 reference

Europe PubMed Central

11 November 2017

Pharmacological interventions for non-ulcer dyspepsia

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001960.PUB3

Long-term prescribing of proton pump inhibitors in general practice

2

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

How do primary care physicians use long-term acid suppressant drugs? A population-based analysis of Dutch general practices

3

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Use of anti-secretory medication: a population-based cohort study

4

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database

6

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Review article: the long-term use of proton-pump inhibitors

8

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Who is using chronic acid suppression therapy and why?

9

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Rabeprazole test for the diagnosis of gastro-oesophageal reflux disease: results of a study in a primary care setting

10

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics

11

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Clinical trial: long-term use of proton pump inhibitors in primary care patients - a cross sectional analysis of 901 patients

14

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs

15

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.

16

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Rising incidence of reflux oesophagitis in patients undergoing upper gastrointestinal endoscopy

17

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy

18

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Long-term treatment of gastro-oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole: on-demand treatment compared with continuous treatment

19

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Proton pump inhibitors: perspectives of patients and their GPs

20

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

21

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Systematic review of the risk of enteric infection in patients taking acid suppression

22

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Gastric acid‐suppressive therapy and community‐acquired respiratory infections

23

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs

24

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture

25

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Proton-pump inhibitors and hypomagnesemic hypoparathyroidism

26

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Ambulatory care increased vitamin B12 requirement associated with chronic acid suppression therapy

27

1 reference

10.1097/MEG.0B013E32833D56D1

https://api.crossref.org/works/10.1097/MEG.0B013E32833D56D1

11 June 2024

Identifiers

10.1097/MEG.0B013E32833D56D1

1 reference

Europe PubMed Central

11 November 2017

1 reference

Europe PubMed Central

11 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42955085&oldid=2176727802"